Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine whether iloprost inhalation solution is
safe in subjects with idiopathic pulmonary fibrosis (IPF) and elevated pulmonary arterial
pressure. The secondary purpose is to evaluate the effectiveness of this treatment in
subjects with this disease.